springworkstx.com (SWTX) - יתרות מזומנים למניה אחת

סמל תאגידי ולוגו של SpringWorks Therapeutics, Inc (SWTX)

The precision oncology market is currently experiencing active growth driven by high demand for innovative treatment methods. SpringWorks Therapeutics (SWTX) is attracting leading biologists to develop targeted therapies, as evidenced by the cash per share metric, which is recorded at 3.82. However, a heavy reliance on regulatory verdicts and the uncertainty of clinical trials create risks of financial instability for the company.

springworkstx.com (SWTX) - מזומנים למניה אחת מ-04.07.2022 עד 12.07.2025

פילוחי מדדים מקיפים ואנליטיקה עבור SpringWorks Therapeutics, Inc (SWTX)

- מחיר שוק ויעדי מחיר של אנליסטים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:SpringWorks - SWTX
סחורת הדגל של SpringWorks

The scale of SpringWorks Therapeutics (SWTX) operations is reflected in the dynamics of the liquid position per share. This indicator is calculated as the ratio of total cash holdings to the number of outstanding securities. It measures the actual financial cushion available to each shareholder to cover operating expenses. For a monopolist in the rare disease niche, this reserve guarantees the uninterrupted approval of drugs. The steady growth of this metric confirms the sustainability of the company's long-term development.